We are pleased to announce that Molzym is now part of the Bruker Corporation.

This is an exciting new chapter in our journey to advance molecular diagnostics and clinical research. It strengthens Bruker's portfolio in these areas and opens up new opportunities for innovation at Molzym.

What does this mean for you?
• No disruption: Our products, services, and supply processes continue as usual.
• Same people, same passion: Your trusted Molzym contacts remain unchanged.

Do you have any questions? Please contact us and we will be happy to arrange a short meeting with you.

We would like to thank you, our customers, distributors, and employees, for all your trust and look forward to continuing our valuable collaboration!

With best regards,
Michael Lustig and the entire Molzym Team